These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2907818)

  • 1. [Cardiac hypertrophy and its response to beta-adrenergic blockade].
    Tsukiyama H; Otsuka K
    Kokyu To Junkan; 1988 Oct; 36(10):1067-73. PubMed ID: 2907818
    [No Abstract]   [Full Text] [Related]  

  • 2. Regression of cardiac hypertrophy with drug treatment in spontaneously hypertensive rats.
    Ruskoaho H
    Med Biol; 1984; 62(5):263-76. PubMed ID: 6152298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of beta adrenoceptor blockade with atenolol on myocardial cellular and subcellular hypertrophy in spontaneously hypertensive rats.
    Lauva IK; Tomanek RJ
    Anat Rec; 1983 Dec; 207(4):615-22. PubMed ID: 6142665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of myocardial hypertrophy in prehypertensive spontaneously hypertensive rats: interaction between adrenergic and nitrosative pathways.
    Cabassi A; Dancelli S; Pattoneri P; Tirabassi G; Quartieri F; Moschini L; Cavazzini S; Maestri R; Lagrasta C; Graiani G; Corradi D; Parenti E; Tedeschi S; Cremaschi E; Coghi P; Vinci S; Fiaccadori E; Borghetti A
    J Hypertens; 2007 Aug; 25(8):1719-30. PubMed ID: 17620971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of salt loading and various therapies on cardiac hypertrophy and fibrosis in young spontaneously hypertensive rats.
    Ziegelhöffer-Mihalovicova B; Arnold N; Marx G; Tannapfel A; Zimmer HG; Rassler B
    Life Sci; 2006 Jul; 79(9):838-46. PubMed ID: 16624325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical alterations in cardiac hypertrophy.
    Khairallah PA; Hanna MK; Tarazi RC; Upsher ME; Yoshida K
    J Hypertens Suppl; 1984 Dec; 2(3):S379-82. PubMed ID: 6242562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular hypertrophy in spontaneously hypertensive rats.
    Sen S; Tarazi RC
    J Hypertens Suppl; 1986 Oct; 4(3):S123-6. PubMed ID: 2946822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-talk between cardiac kappa-opioid and beta-adrenergic receptors in developing hypertensive rats.
    Yu XC; Wang HX; Zhang WM; Wong TM
    J Mol Cell Cardiol; 1999 Mar; 31(3):597-605. PubMed ID: 10198190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differential expression of cardiac immediate early and late response gene in exercise-induced and hypertensive cardiac hypertrophic remodeling].
    Li ZB; Gao YQ; Tang ZS
    Sheng Li Xue Bao; 1998 Oct; 50(5):551-6. PubMed ID: 11367752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical and surgical perspectives of cardiac hypertrophy in Costello syndrome.
    Kalfa D; Fraisse A; Kreitmann B
    Cardiol Young; 2009 Dec; 19(6):644-7. PubMed ID: 19825250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular effects of M17055, furosemide and thiazide on cardiac hypertrophy of spontaneously hypertensive rats.
    Kim S; Hamaguchi A; Shinkawa T; Kato Y; Tsuchiya N; Miura K; Ohta K; Iwao H
    J Pharmacol Exp Ther; 1996 Nov; 279(2):983-90. PubMed ID: 8930208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of sympathetic nervous activity on regression of cardiac hypertrophy.
    Strauer BE; Bayer F; Brecht HM; Motz W
    J Hypertens Suppl; 1985 Dec; 3(4):S39-44. PubMed ID: 2937889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac function as related to adrenergic activity in hypertensive left ventricular hypertrophy.
    Agabiti-Rosei E; Muiesan ML; Romanelli G; Castellano M; Beschi M; Alicandri C; Muiesan G
    J Clin Hypertens; 1987 Jun; 3(2):203-10. PubMed ID: 3039076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of left ventricular hypertrophy in hypertension with alpha-adrenergic blockade: physiological basis and therapeutic implications.
    Ram CV
    J Hypertens Suppl; 1989 Dec; 7(6):S98-9. PubMed ID: 2576672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal transfer in cardiac muscle. Alteration of the beta-adrenoceptor adenylate cyclase system in the hypertrophied myocardium.
    Will-Shahab L; Küttner I; Warbanow W
    Biomed Biochim Acta; 1986; 45(1-2):S199-204. PubMed ID: 3008709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenergic activity and myocardial anatomy and function in essential hypertension.
    Muiesan G; Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1985 Dec; 3(4):S45-50. PubMed ID: 3007705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of non-beta-adrenergic blocking drugs on left ventricular hypertrophy.
    Fouad-Tarazi FM
    Am Heart J; 1987 Oct; 114(4 Pt 2):971-4. PubMed ID: 2959137
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of endocrine factors in the pathogenesis of cardiac hypertrophy.
    Cohen J
    Circ Res; 1974 Aug; 35(2):suppl II:49-57. PubMed ID: 4276488
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypertension-mediated albuminuria is associated with reduced lysosomal activity in the kidney and the heart.
    Hilliard LM; Russo LM; Comper WD
    Am J Nephrol; 2009; 29(5):454-64. PubMed ID: 19023196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.